<DOC>
	<DOCNO>NCT02675400</DOCNO>
	<brief_summary>In contrast mother Attention Deficit/Hyperactivity Disorder ( ADHD ) , impact paternal ADHD family child ADHD symptom study , despite prevalence ADHD male . Thus , investigator know feasibility , impact treatment family child , effect treat father relative mother ADHD . Paternal ADHD associate negative parenting child conduct problem . The investigator hypothesize successfully treat parental ADHD father beneficial effect family extend child . Specifically , investigator believe stimulant medication ( ( Lisdexamfetamine ( LDX ) different ADHD medication poor response LDX ) father reduce father 's ADHD symptom improve parent . Effects stimulant treatment father compare Behavioral Parent Training ( BPT ) parenting , paternal child outcomes father ADHD child age 3 -8 . As investigator 's previous work , investigator bank paternal child DNA RNA later examination pharmacogenetic epigenetic effect ( i.e . RNA ) stimulant response .</brief_summary>
	<brief_title>Treatments Fathers With ADHD Their At-Risk Children ( Fathers Too )</brief_title>
	<detailed_description>The overarch goal research program construct evaluate paternal familial intervention improve trajectory ADHD outcomes at-risk young child ADHD symptom yet treat stimulant medication . These child risk ADHD virtue paternal ADHD maladaptive parenting . Our primary outcome measure child whether child ADHD symptoms Conners Parent Teacher Rating Scales decrease completion study . The primary outcome father Conners Adult ADHD Rating Scale-Self Report Other Report ( CAARS ) , clinician complete Clinical Global Impressions-Severity ( CGI-S ) Barkley Functional Impairment rating Scale ( BFIS ) . Secondary outcome include Family Routines Questionnaire ( FRI ) , Alabama Parent Questionnaire ( APQ ) Dyadic Parent-Child Interaction Coding System ( DPICS ) . Specific Aim 1 : To develop screening recruitment strategy identify father ADHD young child risk ADHD . Specific Aim 2 : To assess comparative efficacy treat father LDX ( different ADHD medication poor response LDX ) functional impairment 8 week treatment . Hypothesis 1a : LDX associate great reduction paternal ADHD symptom ( CAARS , CAARS-Other Informant ) impairment ( CGI-S ) family treat BPT . Hypothesis 1 b : BPT associate great improvement measure parent ( e.g . APQ , DPICS ) family function ( DAS , BFIS ) LDX . To investigator 's knowledge , 2.5 year study first examine benefit identify treat father ADHD prior treat at-risk child . In addition , investigator 's knowledge , first study directly compare impact BPT vs. LDX father child outcome . Thus , investigator 's propose novel treatment strategy uncommon difficult treat patient population : young child risk ADHD virtue early-onset behavior problem environmental factor poor parenting .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Fathers Sign inform consent Be 2155 year old ( inclusive ) screen visit Englishspeaking At screen ( washout , require ) meet full DSMIV criterion ADHD , subtype Current CGISADHD rating â‰¥ 4 &lt; 7 . Findings physical exam ( PE ) , laboratory study , vital sign , electrocardiogram ( ECG ) judge normal age contraindication MPH treatment . Pulse blood pressure ( BP ) within 95 % age gender mean Commit entire visit schedule study . Able complete study assessment . Fathers comorbid mood/anxiety disorder effectively treat antidepressant antianxiety agent eligible participation , provide medication change within 30 day , well tolerate , current mood symptom severe associate active suicidal ideation . Father History allergic reaction severe negative response study medication Active alcohol/substance abuse past 3 month positive urinary toxic screen initial evaluation explain timelimited medical circumstance . Current bipolar illness , schizophrenia , psychosis , significant suicidal risk History chronic acute medical disorder stimulant therapy would contraindicate ( e.g. , glaucoma , hypertension ) . Currently , ( within past 30 day ) receive stimulant medication ADHD . Father seek parentbased intervention course study , Weeks 1 8 . Child Sign assent old six . Be ages 38 . Symptoms ADHD ( Conners Hyperactivity Index Attention &gt; 60 ) . English speaking . No prior treatment effective dose stimulant .</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ADHD</keyword>
	<keyword>ADD</keyword>
	<keyword>Attention Deficit/Hyperactivity Disorder</keyword>
	<keyword>Attention</keyword>
	<keyword>Hyperactivity</keyword>
</DOC>